Efficacy and safety of ixekizumab in psoriatic arthritis: a retrospective, single-centre, observational study in a real-life clinical setting

被引：0
|
作者：
Manfreda, V. [1 ]
Chimenti, M. [2 ]
Canofari, C. [2 ]
Esposito, M. [1 ,3 ]
Perricone, R. [2 ]
Bianchi, L. [1 ]
Giunta, A. [1 ]
机构：
[1] Univ Roma Tor Vergata, Dept Dermatol, Via Montpellier 1, Rome, Italy
[2] Univ Roma Tor Vergata, Dept Rheumatol Allergol & Clin Immunol, Rome, Italy
[3] Univ Aquila, Dept Biotechnol & Appl Clin Sci, Dept Dermatol, Laquila, Italy
来源：
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2020年 / 38卷 / 03期
关键词：
INADEQUATE RESPONSE;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：581 / 582
页数：2
相关论文
共 50 条
  • [21] Real-life data on the safety and tolerability of Pirfenidone versus Nintedanib in Idiopathic Pulmonary Fibrosis (IPF) patients: A single-centre retrospective study
    Yin, Lorraine Thong Wan
    Bowen, Bernadette
    Henry, Micahel
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [22] Real-life efficacy of guselkumab in patients with early psoriatic arthritis
    Pantano, Ilenia
    Mauro, Daniele
    Romano, Francesca
    Gambardella, Alessio
    Valenti, Mario
    Simone, Davide
    Iacono, Daniela
    Costanzo, Antonio
    Argenziano, Giuseppe
    Ciccia, Francesco
    RHEUMATOLOGY, 2022, 61 (03) : 1217 - 1221
  • [23] Real-life drug retention rate and safety of rituximab when treating rheumatic diseases: a single-centre Swiss retrospective cohort study
    Dumusc, Alexandre
    Alromaih, Fahad
    Perreau, Matthieu
    Huegle, Thomas
    Zufferey, Pascal
    Dan, Diana
    ARTHRITIS RESEARCH & THERAPY, 2023, 25 (01)
  • [24] Real-life drug retention rate and safety of rituximab when treating rheumatic diseases: a single-centre Swiss retrospective cohort study
    Alexandre Dumusc
    Fahad Alromaih
    Matthieu Perreau
    Thomas Hügle
    Pascal Zufferey
    Diana Dan
    Arthritis Research & Therapy, 25
  • [25] Efficacy of Bendamustine, Pomalidomide, and Dexamethasone (BPD) Regimen in Relapsed/Refractory Extramedullary Myeloma: A Retrospective Single-Centre Study, Real-Life Experience
    Acar, Ibrahim Halil
    Guvenc, Birol
    HEMATOLOGY REPORTS, 2023, 15 (03) : 465 - 473
  • [26] Real-life evaluation of the clinical, functional, and hematological effects of mepolizumab in patients with severe eosinophilic asthma: Results of a single-centre observational study
    Pelaia, Corrado
    Busceti, Maria Teresa
    Solinas, Sabina
    Terracciano, Rosa
    Pelaia, Girolamo
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2018, 53 : 1 - 5
  • [27] Safety and efficacy of alirocumab in a real-life setting: the ODYSSEY APPRISE study
    Gaudet, Daniel
    Lopez-Sendon, Jose Luis
    Averna, Maurizio
    Bigot, Gregory
    Banach, Maciej
    Letierce, Alexia
    Loy, Megan
    Samuel, Rita
    Manvelian, Garen
    Batsu, Isabela
    Henry, Patrick
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2022, 28 (17) : 1864 - 1872
  • [28] Efficacy and safety of super selective bronchial artery coil embolisation for haemoptysis: a single-centre retrospective observational study
    Ishikawa, Hideo
    Hara, Masahiko
    Ryuge, Misaki
    Takafuji, Jun
    Youmoto, Mihoko
    Akira, Masanori
    Nagasaka, Yukio
    Kabata, Daijiro
    Yamamoto, Kouji
    Shintani, Ayumi
    BMJ OPEN, 2017, 7 (02):
  • [29] Real-life data of etanercept efficacy and safety in juvenile idiopathic arthritis: a 24-month retrospective study at a single center
    Yigit, Ramazan Emre
    Ulu, Kadir
    Caglayan, Sengul
    Sozeri, Betul
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2024, 24 (08) : 855 - 862
  • [30] UPADACITINIB REAL-LIFE EFFICACY AND SAFETY IN PSORIATIC ARTHRITIS: RESULTS AT 24 WEEKS OF A MULTICENTRIC ITALIAN STUDY (UP-REAL)
    Paci, V.
    Luchetti, M. M.
    Carletto, A.
    Zabotti, A.
    Luciano, N.
    Ramonda, R.
    Dagna, L.
    Sandri, G.
    Salvarani, C.
    Chimenti, M. S.
    Possemato, N.
    Piccinelli, A.
    Giovannini, I.
    Striani, G.
    Boffini, N.
    Pantano, I.
    Benfaremo, D.
    Ciccia, F.
    Selmi, C.
    Moroncini, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1778 - 1779
12345